Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank71
3Y CAGR-20.6%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-20.6%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$100000.00-
2024$0.00-100.0%
2023$100000.00-50.0%
2022$200000.00-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-